The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study

The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study

Background: Botulinum toxin type A (BTA) is now extensively used to address cosmetic concerns. OnabotulinumtoxinA (ONA, Botox; Allergan Inc., Irvine, CA) received FDA approval for upper face rejuvenation, including glabella frown lines and crow’s-feet lines. The other off-label uses for lower face c...

Full description

Bibliographic Details
Main Authors: Rungsima Wanitphakdeedecha, Chanida Ungaksornpairote, Arisa Kaewkes, Angkana Sathaworawong, Nittaya Lektrakul, Woraphong Manuskiatti
Format: Article
Language:English
Published: Taylor & Francis Group 2017-07-01
Series:Journal of Dermatological Treatment
Subjects:
botulinum toxin type a
onabotulinumtoxin a
nabota
masseter reduction
Online Access:http://dx.doi.org/10.1080/09546634.2016.1263382

Internet

http://dx.doi.org/10.1080/09546634.2016.1263382

Similar Items